Sun Pharmaceutical Industries Share Price Today - Live Blog for August 13, 2025

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.05%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,639.05, and market participants are assessing the implications. The stock has a PE ratio of 37.5200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.18% increase and currently trading at ₹1,640.95 per share. This upward trajectory is turning heads in the market.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.06% drop, and it's now trading at ₹1,639.45 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.02%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,641.20, and market participants are assessing the implications. The stock has a PE ratio of 37.5200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.04%, reaching the current market price of ₹1,641.60. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

With a -0.01% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,638.90. The stock is currently trading at a PE of 37.5200, while the industry PE is 33.6700, prompting investors to assess its value proposition.

With a -0.01% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,638.90. The stock is currently trading at a PE of 37.5200, while the industry PE is 33.6700, prompting investors to assess its value proposition.

With a -0.18% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,639.00. Investors should examine the factors driving this decline. The stock's PE ratio is 37.5200, whereas the industry PE ratio stands at 33.6700.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.12% increase and currently trading at ₹1,642.40 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.01% surge in its share price and is presently trading at ₹1,639.75. The increased investor interest is driving this surge.

After a significant 0.07% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,641.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Sun Pharmaceutical Industries Ltd experienced a -0.03% dip in its share price and is currently trading at ₹1,638.45. The stock has a PE ratio of 37.5200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.45% upswing, and it's currently trading at ₹1,639.00 per share. Investors are closely watching this development.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.45%, reaching the current market price of ₹1,639.00. This surge is indicative of the stock's recent positive performance.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.18% upswing, and it's currently trading at ₹1,633.75 per share. Investors are closely watching this development.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,630.80 per share. Investors are closely watching this development.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.03%, with its current market value per share resting at ₹1,630.25. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd share price surged by 0.09%. With its current market price standing at ₹1,631.00 per share, this stock is garnering increased attention from the investment community.

With a -0.04% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,629.40. Investors should examine the factors driving this decline. The stock's PE ratio is 37.5200, whereas the industry PE ratio stands at 33.6700.

Following a noteworthy 0.07% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,630.00. When it comes to valuation, this stock has a PE ratio of 37.5200, with the industry PE ratio at 33.6700.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.38% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,628.80, making it an appealing option for investors.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.15%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,623.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd shares saw a -0.15% decrease, reaching a current market price of ₹1,623.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.5200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.05%, with its current market value per share resting at ₹1,623.25. This development highlights the stock's appeal to investors.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.05% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,623.25 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.94% decrease in its share price, and it is currently trading at ₹1,622.80. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.5200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd shares experienced a -0.94% reduction, with the current market price at ₹1,622.80. Investors are carefully considering their positions and seeking insights into the stock's future performance.